BridgeMD
New treatment option for Patella Fracture
Official title Effects Of Intra-Operative Intra-Articular Cocktail Injection In Patella Open Reduction And Internal Fixation
ClinicalTrials.gov ID: NCT07006168
What this study is testing
What is Ketorolac 15mg?
Ketorolac 15mg is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for patella fracture.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The objective of this study is to demonstrate the safety and efficacy of an intra-articular analgesics cocktail injection for post-operative patella fracture fixation patients, by comparing post-operative pain relief and functional recovery among study subjects who received the injection and those who did not receive the injection. Secondary objective is to demonstrate the health economic effects of intra-articular analgesics cocktail injection by reducing length of hospital stay and reducing bed-stay related complications.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- acute patella fracture requiring open reduction and internal fixation;
- able to consent to surgery;
- pre-morbid able to ambulate
You likely can't join if
- open fracture;
- polytrauma;
- previous knee arthroplasty;
- history of chronic pain,
- insulin-dependent diabetes mellitus, or peptic ulcer disease;
- chronic users of glucocorticoids, immunosuppressants, or immune-modulating agents, or of strong opioids (e.g.: morphine, fentanyl, hydromorphone...
See the full eligibility criteria
- acute patella fracture requiring open reduction and internal fixation;
- able to consent to surgery;
- pre-morbid able to ambulate
- open fracture;
- polytrauma;
- previous knee arthroplasty;
- history of chronic pain,
- insulin-dependent diabetes mellitus, or peptic ulcer disease;
- chronic users of glucocorticoids, immunosuppressants, or immune-modulating agents, or of strong opioids (e.g.: morphine, fentanyl, hydromorphone, methadone, oxycodone, or meperidine);
- hepatitis B or C carrier;
- renal impairment (creatinine [Cr], \>200 mmol/L)
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.